Float Short %

4.46

Margin Of Safety %

Put/Call OI Ratio

0.98

EPS Next Q Diff

0.9

EPS Last/This Y

5.09

EPS This/Next Y

5.34

Price

195.57

Target Price

247.45

Analyst Recom

Performance Q

14.43

Relative Volume

0.49

Beta

0.41

Ticker: ASND

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	ASND	198.34	0.96	0.39	16333
2025-08-18	ASND	194.01	1.11	0.01	8481
2025-08-19	ASND	194.3	1.34	2.20	7795
2025-08-20	ASND	191.92	1.34	1.11	7811
2025-08-21	ASND	193.8	1.35	0.15	7864
2025-08-22	ASND	194.13	1.36	0.06	7850
2025-08-25	ASND	190.07	1.36	3.36	7855
2025-08-26	ASND	196.66	1.37	1.83	7944
2025-08-27	ASND	193.04	1.36	0.01	8035
2025-08-28	ASND	194.11	1.12	0.14	8799
2025-08-29	ASND	194.1	1.11	4.38	8809
2025-09-02	ASND	198.82	1.11	0.24	8794
2025-09-03	ASND	199.56	1.10	0.03	8859
2025-09-04	ASND	198.26	0.91	1.99	9783
2025-09-05	ASND	205.91	0.93	0.44	9936
2025-09-08	ASND	205.52	0.93	0.35	9918
2025-09-09	ASND	202.84	0.94	0.46	9924
2025-09-10	ASND	198.73	0.97	0.33	10164
2025-09-11	ASND	197.47	0.98	0.05	10149
2025-09-12	ASND	195.52	0.98	0.64	10141
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	ASND	198.20	82.7	54.3	-2.39
2025-08-18	ASND	194.32	82.7	61.9	-2.39
2025-08-19	ASND	194.62	82.7	58.5	-2.39
2025-08-20	ASND	192.71	84.3	60.3	-2.46
2025-08-21	ASND	192.96	84.3	58.7	-2.46
2025-08-22	ASND	194.30	84.3	57.7	-2.46
2025-08-25	ASND	190.03	84.3	62.2	-2.46
2025-08-26	ASND	196.66	84.3	54.2	-2.46
2025-08-27	ASND	193.02	84.3	61.8	-2.46
2025-08-28	ASND	193.90	84.3	58.4	-2.46
2025-08-29	ASND	194.14	84.3	58.9	-2.46
2025-09-02	ASND	199.27	84.3	55.2	-2.46
2025-09-03	ASND	199.91	84.3	423.7	-2.46
2025-09-04	ASND	198.09	84.3	420.9	-2.46
2025-09-05	ASND	205.91	84.3	429.3	-2.46
2025-09-08	ASND	205.22	84.3	420.6	-2.46
2025-09-09	ASND	202.82	83.5	418.9	-2.51
2025-09-10	ASND	198.46	83.5	416.9	-2.51
2025-09-11	ASND	197.67	83.5	420.6	-2.51
2025-09-12	ASND	195.57	83.5	419.2	-2.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	ASND	0.00	1.26	4.58
2025-08-18	ASND	0.00	0.40	4.58
2025-08-19	ASND	0.00	0.40	4.58
2025-08-20	ASND	0.00	0.40	4.58
2025-08-21	ASND	0.00	0.40	4.58
2025-08-22	ASND	0.00	0.40	4.58
2025-08-25	ASND	0.00	-4.90	4.58
2025-08-26	ASND	0.00	-4.90	4.58
2025-08-27	ASND	0.00	-4.90	4.14
2025-08-28	ASND	0.00	-4.90	4.14
2025-08-29	ASND	0.00	-4.90	4.14
2025-09-02	ASND	0.00	-5.03	4.14
2025-09-03	ASND	0.00	-5.03	4.14
2025-09-04	ASND	0.00	-5.03	4.14
2025-09-05	ASND	0.00	-5.03	4.14
2025-09-08	ASND	0.00	-5.02	4.14
2025-09-09	ASND	0.00	-5.02	4.14
2025-09-10	ASND	0.00	-5.02	4.14
2025-09-11	ASND	0.00	-5.02	4.46
2025-09-12	ASND	0.00	-5.02	4.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.93

Avg. EPS Est. Current Quarter

-0.28

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

-5.02

Beta

0.41

Average Sales Estimate Current Quarter

209

Average Sales Estimate Next Quarter

261

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-61.7

Target Price

247.45

P/E

Forward P/E

50.1

PEG

P/S

22.15

P/B

P/Free Cash Flow

EPS

-4.97

Average EPS Est. Cur. Y

-2.51

EPS Next Y. (Est.)

2.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-54.94

Relative Volume

0.49

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

1.21

EBIT Estimation

419.2

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y